A
Alexandre Abizaid
Researcher at MedStar Washington Hospital Center
Publications - 536
Citations - 14205
Alexandre Abizaid is an academic researcher from MedStar Washington Hospital Center. The author has contributed to research in topics: Stent & Intravascular ultrasound. The author has an hindex of 56, co-authored 498 publications receiving 12650 citations. Previous affiliations of Alexandre Abizaid include Cleveland Clinic & University of São Paulo.
Papers
More filters
Journal ArticleDOI
Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study
J. Eduardo Sousa,Marco A. Costa,Alexandre Abizaid,Andrea Abizaid,Fausto Feres,Ibraim Francisco Pinto,Ana C. Seixas,Rodolfo Staico,Luiz Alberto Mattos,Amanda G. M. R. Sousa,Robert Falotico,Judith Jaeger,Jeffrey J. Popma,Patrick W. Serruys +13 more
TL;DR: In this article, the safety and efficacy of sirolimus-coated BX Velocity stents were evaluated in 30 patients with angina pectoris electively treated with two different formulations of SIROlimuscoated stents (slow release and fast release).
Journal ArticleDOI
Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk
Philip Urban,Ian T Meredith,Alexandre Abizaid,Stuart J. Pocock,Didier Carrié,Christoph Naber,Janusz Lipiecki,Gert Richardt,Andrés Iñiguez,Philippe Brunel,Mariano Valdés-Chávarri,Philippe Garot,Suneel Talwar,Jacques Berland,Mohamed Abdellaoui,Franz R. Eberli,Keith G. Oldroyd,Robaayah Zambahari,John Gregson,Samantha Greene,Hans-Peter Stoll,Marie-Claude Morice +21 more
TL;DR: Among patients at high risk for bleeding who underwent PCI, a polymer-free umirolimus-coated stent was superior to a bare-metal stent with respect to the primary safety and efficacy end points when used with a 1-month course of dual antiplatelet therapy.
Journal ArticleDOI
Three vs Twelve Months of Dual Antiplatelet Therapy After Zotarolimus-Eluting Stents: The OPTIMIZE Randomized Trial
Fausto Feres,Ricardo A. Costa,Alexandre Abizaid,Martin B. Leon,J. Antonio Marin-Neto,Roberto Botelho,Spencer B. King,Manuela Negoita,Minglei Liu,J. Eduardo T. de Paula,José A. Mangione,George César Ximenes Meireles,Hélio José Castello,Eduardo L. Nicolela,Marco Antonio Perin,Fernando Devito,Andre Labrunie,Décio Salvadori,Marcos Gusmão,Rodolfo Staico,J. Ribamar Costa,Juliana P. Castro,Andrea Abizaid,Deepak L. Bhatt +23 more
TL;DR: In patients with stable coronary artery disease or low-risk ACS treated with zotarolimus-eluting stents, 3 months of dual antiplatelet therapy was noninferior to 12 months for NACCE, without significantly increasing the risk of stent thrombosis.
Journal ArticleDOI
The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation
Alexandre Abizaid,Ran Kornowski,Gary S. Mintz,Mun K. Hong,Andrea Abizaid,Roxana Mehran,Augusto D. Pichard,Kenneth M. Kent,Lowell F. Satler,Hongsheng Wu,Jeffrey J. Popma,Martin B. Leon +11 more
TL;DR: In a large consecutive series of patients treated by elective stent implantation, IDDM patients were at higher risk for in-hospital mortality and subsequent TLR and, as a result, had a significantly lower cardiac event-free survival rate.
Journal ArticleDOI
Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial.
Patrick W. Serruys,Muzaffer Degertekin,Kengo Tanabe,Alexandre Abizaid,J. Edouardo Sousa,Antonio Colombo,Giulio Guagliumi,William Wijns,Wietze Lindeboom,Jurgen Ligthart,Pim J. de Feyter,Marie Claude Morice +11 more
TL;DR: Sirolimus-eluting stents are effective in preventing neointimal hyperplasia without creating edge effect and without affecting the plaque burden behind the struts.